Wednesday, November 27, 2024

Personal Injury

Sullivan & Cromwell Leads the Pack with $56 Billion in Health Deals

Sullivan & Cromwell maintained its leading position among law firms working on over $55.7 billion in health care deals announced globally this year, continuing...

Insulin Lawsuits are Seen as an Alternative to Pricing Legislation by PBM

The litigation against insulin manufacturers and pharmacy benefit managers is growing rapidly. This model of litigation has emerged as an effective tool for local...

Increased Hospital Pricing Data Raises Concerns for Employer Plan Costs

Employers that sponsor health plans are beginning to have more options for comparing prices they pay to hospitals as more organizations ramp...

FDA Fails to Regulate Drug Ads on TikTok, Putting Consumers at Risk

The Food and Drug Administration is doing little to cut down on misleading drug claims on social media despite having the power...

States Face Abortion Clinic Closures and Provider Exits After Dobbs Ruling

The impending closure of one of two remaining Wyoming abortion clinics highlights the increasing financial and logistical pressure providers face in the post-Dobbs era,...

FDA cautioned about exceeding its authority with laboratory test regulation proposal

Federal efforts to bring laboratory tests to detect Covid-19, blood infections, cancers, and more under FDA authority received intense scrutiny from stakeholders...

Health Plans Face Complicated Drug Pricing with Cigna-Humana Deal

Employer groups are warily eyeing a possible merger between Cigna Group and Humana Inc. that would set up the industry for less...

Pharmaceutical Companies Prepare for Additional FTC Lawsuits Regarding Mergers and Acquisitions Expected to be Approved

The pharmaceutical sector is preparing for more antitrust litigation after a pivot by US regulators to lawsuits that prioritize clarifying the law...